Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer's Disease: A Preliminary Study
Yen Ying Lim, Victor L Villemagne, Simon M Laws, David Ames, Robert H Pietrzak, Kathryn A Ellis, Karra Harrington, Pierrick Bourgeat, Ashley I Bush, Ralph N Martins, Colin L Masters, Christopher C Rowe, Paul Maruff
PLoS One | PUBLIC LIBRARY SCIENCE | Published : 2014
Related Projects (1)
Funding for the study was provided in part by the study partners [Australian Commonwealth Scientific Industrial and research Organization, Edith Cowan University, Mental Health Research institute, Alzheimer's Australia), National Ageing Research Institute, Austin Health, CogState Ltd., Hollywood Private Hospital, Sir Charles Gardner Hospital]. The study also received support from the National Health and Medical Research Council and the Dementia Collaborative Research Centres program, as well as ongoing funding from the Science and Industry Endowment Fund. The authors also acknowledge the financial support of the Cooperative Research Centre for Mental Health, from the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PM is a full-time employee of CogState Ltd. SML is supported by the Cooperative Research Centre for Mental Health, which is an Australian Response to Reviewers government initiative. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.